Meeder Asset Management’s La Jolla Pharmaceutical Company LJPC Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-4,159
| Closed | -$13K | – | 2479 |
|
|
2022
Q2 | $13K | Sell |
4,159
-153
| -4% | -$478 | ﹤0.01% | 1299 |
|
|
2022
Q1 | $18K | Buy |
+4,312
| New | +$18K | ﹤0.01% | 1342 |
|
|
2021
Q4 | – | Sell |
-4,282
| Closed | -$17K | – | 2632 |
|
|
2021
Q3 | $17K | Hold |
4,282
| – | – | ﹤0.01% | 1487 |
|
|
2021
Q2 | $18K | Buy |
4,282
+2,037
| +91% | +$8.56K | ﹤0.01% | 1503 |
|
|
2021
Q1 | $8K | Buy |
+2,245
| New | +$8K | ﹤0.01% | 1716 |
|
|
2020
Q2 | – | Sell |
-804
| Closed | -$3K | – | 2736 |
|
|
2020
Q1 | $3K | Buy |
804
+789
| +5,260% | +$2.94K | ﹤0.01% | 2044 |
|
|
2019
Q4 | $0 | Buy |
+15
| New | – | ﹤0.01% | 2571 |
|
|
2019
Q3 | – | Sell |
-318
| Closed | -$3K | – | 2378 |
|
|
2019
Q2 | $3K | Buy |
+318
| New | +$3K | ﹤0.01% | 1838 |
|
|
2019
Q1 | – | Sell |
-106
| Closed | -$1K | – | 2009 |
|
|
2018
Q4 | $1K | Buy |
+106
| New | +$1K | ﹤0.01% | 1694 |
|
|
2017
Q2 | – | Sell |
-159
| Closed | -$5K | – | 2109 |
|
|
2017
Q1 | $5K | Sell |
159
-613
| -79% | -$19.3K | ﹤0.01% | 1138 |
|
|
2016
Q4 | $14K | Buy |
+772
| New | +$14K | ﹤0.01% | 706 |
|